Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

4.415 -0.085 (-1.89%)
Streaming Delayed Price Updated: 12:34 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
Earnings Outlook For Bausch Health Companies
Bausch Health Companies (NYSE:BHC) releases its next round of earnings this Tuesday, August 03. Here is Benzinga's essential guide to Bausch Health Companies's Q2 earnings report... 
Via Benzinga
Unusual Options Activity Insight: Bausch Health Companies
Shares of Bausch Health Companies (NYSE:BHC) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $28.94. Sentiment:... 
Via Benzinga
Analyzing Bausch Health Companies's Unusual Options Activity
On Thursday, shares of Bausch Health Companies (NYSE:BHC) saw unusual options activity. After the option alert, the stock price moved down to $28.52. Sentiment: BEARISH Option... 
Via Benzinga
New Month And Half Year
Welcome to H2. In theory, if markets did well in H1 they tend to close the year up. 
Via Talk Markets
Reconsidered Boom
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
Charles River's Jim Foster Beat The Trauma Of Being CEO
Think taking over the family business is easy? Charles River CEO Jim Foster might beg to differ. He's shown that being CEO comes with trauma. 
Via Investor's Business Daily
Fan Hit
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
The 3 Best Stocks to Buy for Summer 2021
Looking for huge winners over the long run? Here are three top picks. 
Via The Motley Fool
Good Times For Gold
Gold is rising some more, in part as an alternative to crypto. 
Via Talk Markets
The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26) I-Mab (NASDAQ: IMAB)... 
Via Benzinga
Exposures COVID-19
Worldwide Upbeat
The US crackdown on cryptocurrencies continues with the Fed today indicating that an official crypto-currency is going to be created for the USA. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Q1 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successful investors have been buying and... 
Via Benzinga
2 Top Turnaround Stocks to Buy Now
These two battered stocks have reignited investors' passion over the past year. Can their momentum last? 
Via The Motley Fool
64 Biggest Movers From Yesterday
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares surged 72.6% to close at $2.14 on Tuesday. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug... 
Via Benzinga
Exposures COVID-19
44 Stocks Moving In Tuesday's Mid-Day Session
Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) shares jumped 75.4% to $2.1750. Cocrystal Pharma recently announced progress on its COVID-19 antiviral drug candidates that target... 
Via Benzinga
Exposures COVID-19
Why Bausch Health Stock Is Falling Today
The company's mixed Q1 results are partially to blame. 
Via The Motley Fool
2 Top Value Stocks to Buy in May
Bausch Health and Albertsons offer excellent bang for your buck. 
Via The Motley Fool
Bausch Health Reports Wider Q1 Loss, Hit By Impairment Charges On Ortho Dermatologics
Bausch Health Companies Inc (NYSE: BHC) reported a deeper first-quarter loss of $610 million compared with a loss of US$152 million a year earlier, impacted... 
Via Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Monday Markets Unhinged
Today's stock market is somewhat unhinged because so many foreign markets are shut for a bank holiday: Britain, China, Thailand, Japan. 
Via Talk Markets
Bausch Health Exploring Potential Divestiture Of Eye Care Units: Bloomberg
Bausch Health Companies Inc (NYSE: BHC) said in August that it would spin off its eye-care unit and operate it as an independent, publicly traded company. As a... 
Via Benzinga
3 Distressed Stocks for Contrarian Investors to Buy in April
Looking for outside-the-box investments in an overvalued market? Here are your best bets. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.